Agency Business Briefs: Cephalon, Draftfcb, Cline Davis & Mann, inVentiv Health and ParagonRx

Share this article:
Cephalon has consolidated its oncology business into Interpublic Group's Draftfcb. The franchise includes Trisenox, which was with WPP's Sudler & Hennessey, and Treanda, which was with Omnicom's LyonHeart. It's a purely professional-facing assignment, as those brands are not currently advertised to consumers. Draftfcb, which previously handled advertising for Nuvigil, will take over the oncology business sometime this quarter, Cephalon said.

Dr. Nan Hayworth, a former Cline, Davis & Mann exec, left the shop to run for US Congress as a Republican in New York's 19th Congressional district. That Hudson Valley district is currently held by Democrat John Hall. An ophthalmologist, Dr. Hayworth was VP medical and scientific affairs at CDM until she launched her Congressional bid.

InVentiv Health acquired ParagonRx, a consulting company specializing in pharma risk management and optimizing medication use. The acquisition is aimed at bolstering inVentiv's Risk Evaluation and Mitigation Strategy offering . In the past year, the network noted, more than a quarter of all new drug approvals in the US included an FDA-approved REMS program.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?